Αρχική World News EMA Recommends Extending Indications for Decitabine / Cedazuridine World News EMA Recommends Extending Indications for Decitabine / Cedazuridine Από Ogkologos - 29 Μαΐου, 2026 292 0 Facebook Twitter Google+ Pinterest WhatsApp New indication concerns a combination with venetoclax for the treatment of adult patients with newly diagnosed AML Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ AI for early cancer detection: where are we now? Could virtual reality become a reality in cancer supportive care? EMA recommends granting a marketing authorisation for daraxonrasib MOST POPULAR Doctor Wipes Away The Debt Of 200 Cancer Patients 6 Ιανουαρίου, 2021 Brentuximab May Mean Less Radiation for Children, Teens with Hodgkin Lymphoma 7 Μαΐου, 2021 No improvement in OS, but more grade 3 or higher AEs... 24 Σεπτεμβρίου, 2026 Advancing Cancer Research as a Married Couple: “Your Stories” Podcast 18 Δεκεμβρίου, 2020 Φόρτωση περισσοτέρων HOT NEWS Worries About Medical Bills May Worsen Health Outcomes After Cancer Diagnosis Women in science: Cancer research pioneers – part 2 FDA Granted Accelerated Approval to Tazemetostat for Follicular Lymphoma Cómo solicitar Medicare cuando tiene cáncer